Research

Jamming the gears of a deadly virus

Fri Nov 13, 2020

NIH

A 3D printed model of a SARS-CoV-2 viral particle (blue) dotted with the spike protein (red) that enables the virus to infect human cells. The spike protein is the target of research efforts to prevent and treat COVID-19.

Team efforts at the School and beyond produce two potential treatments for COVID-19.

Publication Highlight: Meghan Whalen - Aweeka Lab

Thu Nov 12, 2020

Student Publication Highlight:

Resistant bacteria meet their match with custom antibiotics

Mon Oct 26, 2020

Paul Gunning (Cell Image Library)

A scanning electron micrograph image of methicillin resistant staphylococcus aureus (MRSA) bacteria.

“Molecular building blocks” give antibiotics an edge over drug-resistant bacteria.

QBI probes three lethal coronaviruses to find possible drug targets

Fri Oct 23, 2020

Blue dots show MERS-CoV particles on the surface of a cell

National Institute of Allergy and Infectious Diseases (NIAID)

Middle East respiratory syndrome coronavirus (MERS-CoV) viral particles under an electron microscopic.

“This is looking across coronaviruses and finding the commonalities so we’re in a better position to attack SARS3 when it comes,” said Nevan Krogan, the director of QBI.

Study details how California pharmacies could expand naloxone access

Thu Oct 8, 2020

Boxes of Narcan are shown on a shelf in a pharmacy.

Susan Merrell

Narcan is the brand name for naloxone.

“Naloxone saves lives,” says Andy Nguyen. But to work it must be given on a moment's notice.

Shipman receives NIH Director’s New Innovator Award

Tue Oct 6, 2020

Gladstone Institutes

Seth Shipman, PhD

Award funds research into tools for repairing mutations in mitochondrial DNA

Bioartificial kidney aims to mimic natural kidney function with $1 million grant from the John and Marcia Goldman Foundation

Mon Oct 5, 2020

Susan Merrell

The Kidney Project leader Shuvo Roy, PhD

“People struggling with dialysis need and deserve better choices,” said the founders of the foundation.

Customizable synthetic antibiotic outmaneuvers resistant bacteria

Thu Sep 24, 2020

Danica Fujimori Receives Bowes Biomedical Investigator Award

Fri Sep 18, 2020

Danica Galonić Fujimori, PhD

Danica Galonić Fujimori, PhD, will receive $1.25 million in funding over the next five years from the endowment of the late William K. Bowes, Jr., a venture capitalist and longtime UCSF supporter.

Kotis joins leadership of UCSF Health as chief pharmacy executive

Mon Sep 14, 2020

Desi Kotis, PharmD, is UCSF Health's chief pharmacy executive and an associate dean and faculty member in the UCSF School of Pharmacy.

Desi Kotis, PharmD, is committed to bringing the highest level of pharmacy care to patients at UCSF Health.

Categories: Research